drugset / Trial / NCT00876304
Multiple Dose Safety Study of PF-04802540 in Subjects With Schizophrenia
RandomizedParallel-groupDouble-blindBasic science
Summary
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of multiple ascending doses of PF-04802540 administered orally to subjects with schizophrenia.
Timeline
- Start
- 2009-04
- Primary completion
- 2009-09
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-04802540 | Unknown | 5 mg | Oral |
| Subject | PF-04802540 | Unknown | 20 mg | Oral |